- North America
- Other regions
PROGENIKA’s BLOOD GROUP GENOTYPING TEST AVAILABLE THROUGH ARUP LABORATORIESCambridge, MA, October 22, 2009 – Progenika, Inc. today announced that it has entered into an agreement with ARUP Laboratories (ARUP) of Salt Lake City, UT, to provide blood group genotyping reference laboratory services to ARUP to determine patient red blood cell antigen profiles when serology has logistic and functional limitations. Progenika’s blood group genotyping microarray, which simultaneously detects over 100 genetic variants in the nine blood group systems that are most relevant to transfusion safety, overcomes these serological limitations. |
Progenika’s core business is the design and production of in vitro diagnostic tests to be used in the diagnosis and prognosis of genetically complex diseases and prediciting response to therapy.
The ADH test is a diagnostic test for Familial Hypercholesterolemia.
The BGG test was developed to improve the safety of transfusions by genetically characterizing blood group antigens of both donors and recipients.